Matrix metalloproteinases and their biological function in human gliomas

International Journal of Developmental Neuroscience

Volumn 17, Issue 5-6, 1999, Pages 495-502

  Chintala, Shravan K ^a   Tonn, Jorg C ^b   Rao, Jasti S ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Gelatinase; Glioma; Matrix metalloproteases; MT MMP; TIMP

Indexed keywords

GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE;

ARTICLE; CANCER INVASION; ENZYME ACTIVITY; GLIOMA; HUMAN; PRIORITY JOURNAL; SURVIVAL TIME;

BRAIN NEOPLASMS; DISEASE PROGRESSION; GELATINASES; GLIOMA; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; NEOPLASM INVASIVENESS;

EID: 0032844761     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-5748(99)00010-6     Document Type: Article

References (33)

1. Apodaca G., Rutka J.T., Bouhana K., Berens M.E., Giblin J.R., Rosenblum M.L., McKerrow J.H., Banda M.J. Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells. Cancer Research. 50:(8):1990;2322-2329.
2. Arap W., Nishikawa R., Furnari F.B., Cavenee W.K., Huang H.J. Replacement of the p16/CDKN2 gene suppresses human glioma cell growth. Cancer Research. 55:(6):1995;1351-1354.
3. Woessner J.F. Jr. The matrix metalloprotienase family. Parks W.C., Mecham R.P. Matrix metalloproteinases. 1998;1-14 Academic press, San Diego.
4. Brooks P.C., Stromblad S., Sanders L.C., von Schalscha T.L., Aimes R.T., Stetler-Stevenson W.G., Quigley J.P., Cheresh D.A. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell. 85:(5):1996;683-693.
5. Chintala S.K., Sawaya R., Aggarwal B.B., Majumder S., Giri D.K., Kyritsis A.P., Gokaslan Z.L., Rao J.S. Induction of matrix metalloproteinase-9 requires a polymerized actin cytoskeleton in human malignant glioma cells. J. Biol. Chem. 273:(22):1998;13545-13551.
6. Deryugina E.I., Bourdon M.A., Luo G.X., Reisfeld R.A., Strongin A. Matrix metalloproteinase-2 activation modulates glioma cell migration. J. Cell Sci. 110:1997;2473-2482.
7. Deryugina E.I., Bourdon M.A., Reisfeld R.A., Strongin A. Remodelling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase-2. Cancer Res. 58:(16):1998;3743-3750.
8. d'Ortho M.P., Will H., Atkinson S., Butler G., Messent A., Gavrilovic J., Smith B., Timpl R., Zardi L., Murphy G. Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur. J. Biochem. 250:(3):1997;751-757.
9. Edvardsen K., Chen W., Rucklidge G., Walsh F.S., Obrink B., Bock E. Transmembrane neural cell-adhesion molecule (NCAM), but not glycosyl-phosphatidylinositol-anchored NCAM, down-regulates secretion of matrix metalloproteinases. Proc. Natl. Acad. Sci. U.S.A. 90:(24):1993;11463-11467.
10. Lampert K., Machein U., Machein M.R., Conca W., Peter H.H., Volk B. Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors. Am. J. Pathol. 153:(2):1998;429-437.
11. Matrisian L.M. The matrix-degrading metalloproteinases. Bioessays. 14:(7):1992;455-463.
12. Matsuzawa K., Fukuyama K., Dirks P.B., Hubbard S.L., Murakami M., Becker L.E., Rutka J.T. Expression of stromelysin 1 in human astrocytoma cell lines. J. Neuro-Oncol. 30:1996;181-188.
13. Migita K., Eguchi K., Kawabe Y., Ichinose Y., Tsukada T., Aoyagi T., Nakamura H., Nagataki S. TNF-alpha-mediated expression of membrane-type matrix metalloproteinase in rheumatoid synovial fibroblasts. Immunology. 89:(4):1996;553-557.
14. Mohanam S., Chintala S.K., Go Y., Bhattacharya A., Venkaiah B., Boyd D., Gokaslan Z.L., Sawaya R., Rao J.S. In vitro inhibition of human glioblastoma cell line invasiveness by antisense uPA receptor. Oncogene. 14:(11):1997;1351-1359.
15. Mohanam S., Wang S.W., Rayford A., Yamamoto M., Sawaya R., Nakajima M., Liotta L.A., Nicolson G.L., Stetler-Stevenson W.G., Rao J.S. Expression of tissue inhibitors of metalloproteinases: negative regulators of human glioblastoma invasion in vivo. Clin. Exp. Metast. 13:(1):1995;57-62.
16. Nakagawa T., Kubota T., Kabuto M., Sato K., Kawano H., Hayakawa T., Okada Y. Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. J. Neurosurg. 81:(1):1994;69-77.
17. Nakano A., Tani E., Miyazaki K., Yamamoto Y., Furuyama J. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. J. Neurosurg. 83:1995;298-307.
18. Ohuchi E., Imai K., Fujii Y., Sato H., Seiki M., Okada Y. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J. Biol. Chem. 272:(4):1997;2446-2451.
19. Parker S.L., Tong T., Bolden S., Wingo P.A. Cancer statistics. CA Cancer J. Clin. 47:1997;5-27.
20. Puente X.S., Pendas A.M., Llano E., Velasco G., Lopez-Otin C. Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma. Cancer Res. 56:(5):1996;944-949.
21. Rao J.S., Steck P.A., Mohanam S., Stetler-Stevenson W.G., Liotta L.A., Sawaya R. Elevated levels of M(r) 92,000 type IV collagenase in human brain tumors. Cancer Res. 53:(10 Suppl.):1993;2208-2211.
22. Rutka J.T., Hubbard S.L., Fukuyama K., Matsuzawa K., Becker L.E., Stetler-Stevenson W., Dirks P.B. Expression of TIMP-1, TIMP-2, 72-kDa and 92-kDa type IV collagenase transcript in human astrocytoma cell lines: correlation with astrocytoma cell invasiveness. Int. J. Oncol. 6:1995;877-884.
23. Sato H., Takino T., Okada Y., Cao J., Shinagawa A., Yamamoto E., Seiki M. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature. 370:(6484):1994;61-65.
24. Strongin A.Y., Collier I., Bannikov G., Marmer B.L., Grant G.A., Goldberg G.I. Mechanism of cell surface activation of 72-kDa type IV collagenase: isolation of the activated form of the membrane metalloprotease. J. Biol. Chem. 270:(10):1995;5331-5338.
25. Takino T., Sato H., Shinagawa A., Seiki M. Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. MT-MMPs form a unique membrane-type subclass in the MMP family. J. Biol. Chem. 270:(39):1995;23013-23020.
26. Thant A.A., Serbulea M., Kikkawa F., Liu E., Tomoda Y., Hamaguchi M. c-Ras is required for the activation of the matrix metalloproteinases by concanavalin A in 3Y1 cells. FEBS Lett. 406:(1-2):1997;28-30.
27. Tomasek J.J., Halliday N.L., Updike D.L., Ahern-Moore J.S., Vu T.K., Liu R.W., Howard E.W. Gelatinase A activation is regulated by the organization of the polymerized actin cytoskeleton. J. Biol. Chem. 272:(11):1997;7482-7487.
28. Van Wart H.E., Birkedal-Hansen H. The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family Proc. Natl. Acad. Sci. U.S.A. 87:(14):1990;5578-5582.
29. Wilhelm S.M., Collier I.E., Marmer B.L., Eisen A.Z., Grant G.A., Goldberg G.I. SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J. Biol. Chem. 264:(29):1989;17213-17221.
30. Will H., Hinzmann B. cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment. Eur. J. Biochem. 231:(3):1995;602-608.
31. Yamamoto M., Mohanam S., Sawaya R., Fuller G.N., Seiki M., Sato H., Gokaslan Z.L., Liotta L.A., Nicolson G.L., Rao J.S. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Cancer Res. 56:(2):1996;384-392.
32. Yu, Q., and Stamenkovic, I. Abstract. 2.2 VII international congress of the metastatic research society, San Diego, CA, 1998.
33. Yu A.E., Hewitt R.E., Kleiner D.E., Stetler-Stevenson W.G. Molecular regulation of cellular invasion-role of gelatinase A and TIMP-2. Biochem. Cell Biol. 74:(6):1996;823-831.